Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
CNBC· 19 小時前... on Friday said it would stop developing the twice-daily version of its experimental weight ...
Weight-Loss Drugs Are a Gold Mine, and Just as Elusive
Bloomberg· 13 小時前On Friday, Pfizer Inc. announced that it’s dropping development of an experimental weight-loss ...
Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly
CNBC· 12 小時前Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and ...
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
Reuters· 17 小時前Some leading U.S. obesity specialists say they expect Eli Lilly’s (LLY.N) powerful weight-loss ...
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Reuters· 19 小時前Counseling on diet and exercise alone has failed for decades, he told about 400 doctors taking ...
Wall Street will try to keep the November momentum going in the final month of 2023
CNBC· 12 小時前Stocks ended a three-month losing streak this week, with the Dow Jones Industrial Average on Th ...
US stocks rally on hopes US rates have peaked - RTHK
RTHK· 9 小時前US stocks rallied and the S&P registered its highest close of the year on Friday, starting ...
Wall St Week Ahead Tax-loss selling, 'Santa rally' could sway U.S. stocks after ...
Reuters· 6 小時前As U.S. stocks sit on hefty gains at the close of a rollercoaster year, investors are eyeing ...
5 things to know before the stock market opens Friday
CNBC· 18 小時前Stocks enter the final month of the year Friday with some decent momentum at their backs. The ...
Resurgent S&P 500 crests new 2023 closing high after roller-coaster year
Reuters· 9 小時前A searing late-year rally has brought the S&P 500 (.SPX) to a fresh 2023 closing high, as ...
